Cargando…
Impact of a structured patient support program on adherence and persistence in basal insulin therapy for type 2 diabetes
OBJECTIVE: Treatment adherence and persistence are essential to achieving therapeutic goals in diabetes and may be improved by patient support programs (PSPs). The COACH Program was launched in 2015 with the goal of supporting patients with diabetes who are prescribed insulin glargine 300 U/mL (Gla-...
Autores principales: | Zhou, Fang Liz, Yeaw, Jason, Karkare, Swapna U, DeKoven, Mitch, Berhanu, Paulos, Reid, Timothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307592/ https://www.ncbi.nlm.nih.gov/pubmed/30622720 http://dx.doi.org/10.1136/bmjdrc-2018-000593 |
Ejemplares similares
-
Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes
por: Mocarski, Michelle, et al.
Publicado: (2018) -
Quality of life in patients with type 2 diabetes after switching to insulin degludec: results from a cross-sectional survey
por: Uzoigwe, Chioma, et al.
Publicado: (2021) -
1255. Single-tablet Regimens (STR) Offer Better Persistence and Adherence, with Lower Costs by Adherence Status, than Multiple-tablet Regimens (MTR) for People Living with HIV (PLWH) Enrolled in Medicaid
por: Brogan, Andrew P, et al.
Publicado: (2022) -
“Real‐World” Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States
por: Larmore, Cynthia, et al.
Publicado: (2015) -
Real‐world evidence concerning clinical and economic outcomes of switching to insulin glargine 300 units/mL vs other basal insulins in patients with type 2 diabetes using basal insulin
por: Zhou, Fang Liz, et al.
Publicado: (2018)